Frank Verwiel

Frank Verwiel is a board member at Intellia Therapeutics. Frank has also served on the boards of ObsEva SA, Achillion Pharmaceuticals, Inc., AveXis, Inc., and Bavarian Nordic. Frank was previously the president and CEO of Aptalis Pharma and vice-president of global marketing at Merck.

Frank Verwiel has a MBA from INSEAD, a M.D. from Erasmus University Rotterdam, and a PPL in Business Administration and Management, General from Harvard Business School.